Metformin tablets: kidney checks, stomach side effects and sick days
Metformin hydrochloride is a tablet for type 2 diabetes from the biguanide group, and it is usually the first medicine tried when diet and exercise alone do not control blood sugar well enough. Its dose depends on your kidney function, and it is paused in a few situations you should know in advance. This page sets out the doses in the summary of product characteristics, the side effects, the checks the doctor asks for and when you need urgent help.
What metformin is and which products contain it
Metformin hydrochloride belongs to the biguanides, a group of medicines that lower blood sugar. It is a tablet, not an injection, and it is not insulin. In the Medicines Authority register there are 29 authorised medicines that contain metformin on its own, all classed as prescription-only medicines (POM). They include film-coated tablets of 500 mg, 850 mg and 1000 mg, such as Brotmin, and prolonged-release tablets, which release the medicine more slowly.
The register also lists 116 authorised combination tablets that contain metformin together with a second substance, all POM, and several combinations are authorised centrally in the EU, among them metformin with dapagliflozin, linagliptin, sitagliptin or empagliflozin. This matters for one practical reason: if you already take a combination tablet, adding plain metformin means taking the same substance twice. Check the composition on the pack, not the name, and ask a pharmacist if you are not sure.
What metformin is used for
According to the summary of product characteristics, metformin is used to treat type 2 diabetes, particularly in people who are overweight, when diet and exercise alone do not control blood sugar well enough. In adults it can be used on its own or with other diabetes tablets or with insulin. In children from 10 years of age and in adolescents it can be used on its own or with insulin.
The product information also describes a reduction in diabetes complications in overweight adults who took metformin as their first medicine after diet alone had not worked. In the UKPDS study it describes, the overweight group treated with metformin had fewer diabetes-related complications and deaths than the group treated with diet alone.
The medicine does not replace diet and activity. The package leaflet says plainly that it cannot replace the benefits of a healthy lifestyle and that you continue your diet and regular exercise. How the disease itself presents is described in our guide to the symptoms of type 2 diabetes, and the other groups of diabetes medicines on our page on diabetes medicines.
How metformin works
Metformin acts in several ways. It reduces the amount of glucose the liver produces, helps the body's tissues take up glucose, in part by increasing the action of your own insulin, and changes how glucose is handled in the gut, so that less is absorbed from food. It does not make the pancreas release more insulin, and that explains much of what follows.
Because it does not stimulate insulin release, metformin taken on its own does not cause low blood sugar (hypoglycaemia). Caution is needed when it is combined with insulin or with other diabetes tablets such as sulfonylureas, because those combinations can cause it. Knowing the signs of low blood sugar that the package leaflet lists, such as weakness, dizziness, sweating, a fast heartbeat, vision problems or difficulty concentrating, is part of treatment when such combinations are used.
In clinical studies, body weight stayed stable or fell modestly with metformin. The effect on blood sugar is judged on laboratory results, above all HbA1c, compared with your result before treatment, rather than on how you feel.
Doses in the summary of product characteristics
The dose is set by the doctor and adjusted to your blood sugar results. For adults with normal kidney function, the summary of product characteristics gives a usual starting dose of 500 mg or 850 mg two or three times a day, taken during or after meals. After 10 to 15 days the dose is adjusted on the basis of blood glucose measurements, and a slow increase can help the stomach tolerate it. The maximum is 3 g a day, taken as three doses.
When kidney function is reduced, the maximum daily dose is lower. With a GFR of 30 to 59 mL/min, factors that raise the risk of lactic acidosis are reviewed before starting, and the starting dose is at most half of the maximum:
| Kidney function (GFR, mL/min) | Maximum total daily dose in the summary of product characteristics, split into 2 or 3 doses |
|---|---|
| 90 or more | 3 g |
| 60 to 89 | 3 g; a lower dose may be considered as kidney function falls |
| 45 to 59 | 2 g |
| 30 to 44 | 1 g |
| Below 30 | Metformin must not be used |
How you take the tablets
The Brotmin leaflet asks you to take the tablets with or after a meal, which helps avoid stomach side effects, and to swallow each tablet with a glass of water without crushing or chewing it. One daily dose is taken at breakfast; two doses at breakfast and the evening meal; three doses at breakfast, lunch and the evening meal. Prolonged-release tablets have their own instructions, so follow the leaflet for the pack you have.
If you forget a dose, do not take a double dose to make up for it; take the next dose at the usual time. For children from 10 years of age, the usual starting dose is 500 mg or 850 mg once a day, with a maximum of 2 g a day, and treatment between 10 and 12 years is only on specific advice from the doctor.
Kidney checks and other monitoring
Metformin builds up in the body when kidney function suddenly worsens, and that build-up raises the risk of lactic acidosis. The summary of product characteristics therefore asks for kidney function (GFR) to be measured before treatment starts and at least once a year after that, and more often, for example every three to six months, in older people and in people whose kidney function is likely to worsen.
The usual laboratory tests for monitoring diabetes are done regularly, and HbA1c is the main one. Metformin can lower vitamin B12 levels, and the risk rises with a higher dose, a longer treatment and other risk factors for low vitamin B12. If anaemia or nerve symptoms such as tingling in the hands or feet suggest a deficiency, vitamin B12 is checked, and periodic checks may be needed if you have risk factors.
In stable long-term heart failure, metformin can be used with regular checks of the heart and kidneys. In acute or unstable heart failure it is not used.
Who should not take metformin
The summary of product characteristics lists situations in which metformin must not be used. These are contraindications, not simply reasons for extra care.
- Allergy to metformin or to any other ingredient of the tablet
- Any type of acute metabolic acidosis, such as lactic acidosis or diabetic ketoacidosis, and diabetic pre-coma
- Severe kidney failure, with a GFR below 30 mL/min
- Acute conditions that can affect the kidneys, such as dehydration, a severe infection or shock
- Diseases that can starve the tissues of oxygen, particularly when acute or worsening, such as decompensated heart failure, respiratory failure, a recent heart attack or shock
- Liver failure, acute alcohol intoxication or alcoholism
When metformin is paused
There are three situations in which metformin is stopped for a while, and it is worth knowing them before they happen. If you become dehydrated through severe diarrhoea or vomiting, fever or drinking too little, metformin is stopped temporarily and you contact a healthcare professional. Before or at the time of a scan with an iodine-containing contrast medium injected into a vein, metformin is stopped and restarted no earlier than 48 hours afterwards, once kidney function has been checked and found stable.
For surgery under general, spinal or epidural anaesthesia, metformin is stopped at the time of the operation and restarted no earlier than 48 hours after the surgery or after you start eating and drinking again, again only once kidney function has been checked and found stable. The doctor who orders the scan or the operation tells you when to stop and when to restart; do not decide either step yourself.
Metformin is also not recommended in known mitochondrial diseases such as MELAS syndrome or maternally inherited diabetes and deafness (MIDD), because of the risk of worsening lactic acidosis and neurological problems.
Lactic acidosis: the warning signs
Lactic acidosis is a very rare but serious build-up of acid in the blood. It occurs most often when kidney function suddenly worsens, in heart or lung illness or in a severe infection, and other risk factors include drinking too much alcohol, liver failure, poorly controlled diabetes, prolonged fasting and conditions that starve the tissues of oxygen.
- Vomiting, or abdominal pain together with muscle cramps
- Difficult or deep breathing
- Marked weakness and a general feeling of being unwell with severe tiredness
- Feeling cold, a lower body temperature or a slower heartbeat
- Severe drowsiness, which can progress to loss of consciousness
What to do if you notice these signs
If you notice signs of lactic acidosis, stop taking metformin and seek medical attention at once, because it can lead to a coma. In an emergency, call 112 or go to Accident and Emergency. The same applies if you have taken more metformin than you should.
The same urgency applies to signs of a severe allergic reaction, such as swelling of the face, lips or tongue with difficulty breathing. Signs of very high blood sugar with vomiting, deep breathing and drowsiness are also an emergency, whatever medicines you take.
Medicines and alcohol that interact with metformin
Alcohol intoxication raises the risk of lactic acidosis, particularly when you are fasting, poorly nourished or have liver problems, so drinking heavily is not recommended with metformin. Iodine-containing contrast media are one reason for a temporary pause, as described above.
Some medicines can affect kidney function and so raise the risk of lactic acidosis: anti-inflammatory painkillers (NSAIDs), including COX-2 inhibitors, blood pressure medicines from the ACE inhibitor and angiotensin II receptor antagonist groups, and diuretics, especially loop diuretics. When such a medicine is started or used with metformin, kidney function is monitored closely. Steroid medicines (glucocorticoids) and sympathomimetics can raise blood sugar, so blood sugar may need checking more often while they are used.
Some medicines change the level or effect of metformin: verapamil may reduce its effect, rifampicin may increase it, and cimetidine, dolutegravir, ranolazine, trimethoprim, vandetanib and isavuconazole may increase the amount in the blood. Tell the doctor about every medicine you take, including non-prescription medicines and herbal products.
Metformin side effects
Stomach and bowel complaints are the most common side effects, especially when treatment starts. They usually go away on their own, and taking metformin in two or three doses during or after meals and increasing the dose slowly helps prevent them.
| How often | Side effects in the summary of product characteristics |
|---|---|
| Very common (more than 1 in 10) | Nausea, vomiting, diarrhoea, abdominal pain and loss of appetite, mostly at the start of treatment |
| Common (up to 1 in 10) | Taste disturbance; low vitamin B12 levels |
| Very rare (up to 1 in 10,000) | Lactic acidosis; abnormal liver tests or hepatitis that resolve when metformin is stopped; skin reactions such as redness, itching and hives |
Pregnancy and breast-feeding
Poorly controlled blood sugar around conception and during pregnancy is linked with a higher risk of birth defects, pregnancy loss, high blood pressure in pregnancy, pre-eclampsia and death of the baby around birth, so keeping blood sugar as close to normal as possible matters for you and your child. The summary of product characteristics states that a large amount of data shows no increased risk of birth defects after metformin around conception or in pregnancy, and that metformin can be considered in pregnancy, if clinically needed, as an addition or an alternative to insulin.
Metformin passes into breast milk. No adverse effects were seen in breastfed babies, but because the data are limited, breast-feeding is not recommended during treatment, and the decision is weighed with the doctor. If you are pregnant or planning a pregnancy, the treatment is reviewed by the doctor who manages your diabetes.
How the doctor assesses a request for metformin
You fill in a medical questionnaire about the medicine, your health and other medicines you take, whether metformin has already been started for you or you have not taken it before. The doctor may ask for a recent HbA1c and a recent measure of kidney function, because the dose depends on them. A first prescription needs clear indications in your answers; otherwise the doctor may ask for recent results, recommend that you see a doctor in Malta or decline.
If the doctor has questions, they ask them in writing in the chat in your account, and you get an email to let you know. There is no video call, no phone call and no live chat. For some conditions, and in some individual cases, it is advisable to see a doctor in person; the doctor may recommend this. The warning signs above are never handled this way.
If the doctor issues a prescription, you receive it as a PDF by email. You print it and bring it on paper to a pharmacy in Malta together with photo identification. Your prescription is issued in the standard EU cross-border format set out in Directive 2012/52/EU. A pharmacy in Malta may dispense it; the decision rests with the pharmacist. Take the prescription to a pharmacy within six months of the date on it; a prescription for an antibiotic cannot be dispensed more than ten days after its date of issue.
What does it cost?
Two separate costs are involved. The button on this page shows the fee for the doctor's review, and metformin itself is paid for at the pharmacy, which can tell you the price of your pack. It is not an ePrescription and does not appear in myHealth; it is outside POYC and the Government Formulary List, and you pay for the medicine at the pharmacy in full.
The fee covers the medical consultation, not the issuing of a document. If the doctor declines on medical or legal grounds, we refund the fee. If the doctor asks you for documents, you have at least 7 days to send them in and we send you a reminder; if you ask us, we agree a longer deadline. If the case still cannot be completed, we close the request, let you know and refund the fee in full.
Who reviews your request?
Your request is reviewed by Damian Wojno, a doctor registered with the Polish Medical Chamber, licence no. 3211301. The doctor is not registered with the Medical Council of Malta.
Is metformin prescription-only in Malta?
In the Medicines Authority register, all 29 authorised medicines that contain metformin on its own are classed as prescription-only medicines (POM), for example Brotmin 500 mg film-coated tablets (MA032/14201), and so are all 116 authorised combination tablets that contain metformin. A doctor decides whether to start it, at what dose and in which form, because the dose depends on your kidney function and the rest of your treatment.
What is the usual starting dose of metformin?
For adults with normal kidney function, the summary of product characteristics gives 500 mg or 850 mg two or three times a day, during or after meals, adjusted after 10 to 15 days on the basis of blood glucose results, up to a maximum of 3 g a day. With reduced kidney function the maximum is lower, and below a GFR of 30 mL/min metformin is not used. Your own dose is the one the doctor sets.
What are the most common metformin side effects?
Nausea, vomiting, diarrhoea, abdominal pain and loss of appetite are very common, mostly at the start of treatment, and they usually settle on their own. Taking the tablets during or after meals and increasing the dose slowly helps. A change in taste and low vitamin B12 levels are common. Lactic acidosis is very rare but serious: vomiting, abdominal pain with muscle cramps, difficult breathing, marked weakness and feeling cold mean stopping metformin and getting medical help at once.
Can you drink alcohol while taking metformin?
The summary of product characteristics lists alcohol among the combinations that are not recommended, because alcohol intoxication raises the risk of lactic acidosis, particularly when you are fasting, poorly nourished or have liver problems. Alcoholism is a contraindication. If you drink at all, discuss the amount with the doctor who manages your diabetes.
Why does the doctor ask for kidney results?
Because metformin builds up in the body when kidney function worsens, and that raises the risk of lactic acidosis. Kidney function sets the maximum dose and decides whether metformin can be used at all, so it is measured before treatment and at least once a year, and more often in older people and when kidney function is likely to worsen.
When should metformin be paused?
When you are dehydrated through severe diarrhoea or vomiting, fever or drinking too little, before or at the time of a scan with an iodine-containing contrast medium, and at the time of surgery under general, spinal or epidural anaesthesia. After a scan or surgery it is restarted no earlier than 48 hours later, once kidney function has been checked. Contact a healthcare professional rather than deciding the pause and restart yourself.
What should you do if you miss a dose of metformin?
Do not take a double dose to make up for the forgotten one; take the next dose at the usual time, as the package leaflet says. If you often forget doses, or the effect seems too strong or too weak, talk to your doctor or pharmacist.
Can a pharmacy in Malta dispense a prescription from a doctor in another EU country?
A prescription from a doctor in another EU country can be dispensed in Malta (Article 81(3) of the Medicines Act, Cap. 458) if the pharmacist can confirm the doctor's licence. The decision rests with the pharmacist, who may refuse. You bring the prescription on paper together with photo identification.
- Medicines Authority: Brotmin 500mg film-coated tablets, metformin (MA032/14201), with summary of product characteristics and package leaflet
- Medicines Authority: Diamicron MR Tablets 60, gliclazide (MA066/00603), with package leaflet
- EMA: Synjardy (empagliflozin and metformin), European public assessment report
- Medicines Authority: prescription-only and non-prescription medicines
- Medicines Act (Cap. 458), Article 81 (legislation.mt)
- Prescription and Dispensing Requirements Rules (S.L. 458.49), rule 4 (legislation.mt)
- Commission Implementing Directive 2012/52/EU on the recognition of medical prescriptions issued in another Member State (EUR-Lex)